The CVC market is projected to grow from USD 2,861.0 million in 2024 to USD 5,436.8 million by 2034 at a CAGR of 6.6%.

Central venous catheter-related blood stream infection (CRBSI) is a major cause of morbidity and mortality in patients with end-stage renal disease treated with chronic hemodialysis. Risk factors ...

Peripherally inserted central catheters (PICCs) are frequently used to obtain central venous access for patients in acute care, home care and skilled nursing care. PICCs are a reliable alternative ...

Most participants (53.8%) had three or more coexisting medical conditions, and 41.0% had previously undergone central venous catheter placement. The inserted PICCs in this trial were most commonly ...

Injecting a central venous line has long been a backup plan under the state's official execution policy, but it has never ...

“As the market leader in both Central Venous Catheters (CVCs) 1 and Arterials 2, we are pleased to offer Vizient provider-customers one of the broadest portfolios of vascular access products ...

Central Venous Catheters All catheters consists of high flexible thin-walled polyurethane which ensures very high flow rates. It is anti-thrombogen and biocompatible. At body temperature it gets ...

Effective January 1, 2025, the agreement grants Vizient’s members access to Teleflex’s Central Venous Access Catheters and Arterial Catheters under pre-negotiated terms, enhancing cost ...

Insertion of any catheter in the upper extremity ... to the superior vena cava and minimizes potential venous damage. [17] Insertion of any central VAD must be performed judiciously, as every ...